Compounds > emoxypine succinate
Page last updated: 2024-09-03

emoxypine succinate and ADDH

emoxypine succinate has been researched along with ADDH in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Batysheva, TT; Bykova, OV; Gaynetdinova, DD; Levitina, EV; Mashin, VV; Maximova, NE; Platonova, AN; Suvorinova, NY; Vakula, IN; Zavadenko, NN1
Suvorinova, NY; Zavadenko, AN; Zavadenko, NN1

Trials

1 trial(s) available for emoxypine succinate and ADDH

ArticleYear
[Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:4

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Picolines; Tablets

2022

Other Studies

1 other study(ies) available for emoxypine succinate and ADDH

ArticleYear
[The possibilities of Mexidol usage in neuropediatrics].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Volume: 123, Issue:9. Vyp. 2

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System; Child; Female; Humans; Hypoxia-Ischemia, Brain; Picolines; Pregnancy

2023